- Home
- IRWD vs ANIX Comparison
IRWD vs ANIX Comparison
Compare IRWD & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRWD
- ANIX
- Stock Information
- Founded
- IRWD 1998
- ANIX 1982
- Country
- IRWD United States
- ANIX United States
- Employees
- IRWD N/A
- ANIX N/A
- Industry
- IRWD Biotechnology: Pharmaceutical Preparations
- ANIX Biotechnology: Pharmaceutical Preparations
- Sector
- IRWD Health Care
- ANIX Health Care
- Exchange
- IRWD Nasdaq
- ANIX Nasdaq
- Market Cap
- IRWD 111.2M
- ANIX 108.9M
- IPO Year
- IRWD 2010
- ANIX 1987
- Fundamental
- Price
- IRWD $1.03
- ANIX $2.97
- Analyst Decision
- IRWD Buy
- ANIX Strong Buy
- Analyst Count
- IRWD 5
- ANIX 3
- Target Price
- IRWD $4.94
- ANIX $9.00
- AVG Volume (30 Days)
- IRWD 1.5M
- ANIX 92.2K
- Earning Date
- IRWD 08-07-2025
- ANIX 09-05-2025
- Dividend Yield
- IRWD N/A
- ANIX N/A
- EPS Growth
- IRWD N/A
- ANIX N/A
- EPS
- IRWD N/A
- ANIX N/A
- Revenue
- IRWD $308,519,000.00
- ANIX N/A
- Revenue This Year
- IRWD N/A
- ANIX N/A
- Revenue Next Year
- IRWD N/A
- ANIX N/A
- P/E Ratio
- IRWD N/A
- ANIX N/A
- Revenue Growth
- IRWD N/A
- ANIX N/A
- 52 Week Low
- IRWD $0.53
- ANIX $2.07
- 52 Week High
- IRWD $5.21
- ANIX $4.20
- Technical
- Relative Strength Index (RSI)
- IRWD 63.45
- ANIX 42.09
- Support Level
- IRWD $0.81
- ANIX $3.00
- Resistance Level
- IRWD $1.16
- ANIX $3.10
- Average True Range (ATR)
- IRWD 0.11
- ANIX 0.16
- MACD
- IRWD 0.02
- ANIX -0.02
- Stochastic Oscillator
- IRWD 70.45
- ANIX 16.28
About IRWD Ironwood Pharmaceuticals Inc.
Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.